ClinicalTrials.govpublic full text
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
respiratory syncytial virus infections
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 181613
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.